Literature DB >> 11534640

Immunological and biochemical analysis of glycosylated surface antigens and lipophosphoglycan of Tritrichomonas foetus.

B N Singh1, R H BonDurant, C M Campero, L B Corbeil.   

Abstract

Immunoaffinity-purified TF1.17 adhesin antigen was compared biochemically and antigenically to Tritrichomonas foetus (TF) lipophosphoglycan (LPG) and a soluble glycosylated antigen (SGA) released from T. foetus and implicated in pathogenesis and immunity. The monoclonal antibodies (Mabs TF1.15 and TF1.17) specific for a glycosylated TF1.17 antigen were previously shown to prevent adhesion of the T. foetus parasites to bovine vaginal epithelial cells and to mediate killing by bovine complement. SGA was isolated from T. foetus-conditioned buffer and purified by octyl-Sepharose hydrophobic column chromatography. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of SGA showed a major SGA1 component (approximately 190 kDa) and a minor SGA2 component (50-70 kDa), which migrated close to TF-LPG and TF1.17. The carbohydrate and lipid compositional analyses of affinity-purified TF1.17 and SGA2 by high-performance liquid chromatography (HPLC) and gas-liquid chromatography revealed the presence of monosaccharides and fatty acids as found in TF-LPG. All antigens contained terminal fucose as determined by alpha-fucosidase digestion followed by HPLC. ELISA and western blots were used to further characterize these glycosylated antigens and to analyze their relationships. The Mabs TF1.15 and TF1.17 reacted very strongly to TF-LPG and SGA2. as well as TF1.17 antigen, indicating that these molecules share common epitopes. These Mabs did not react with the SGA1 component either in ELISA and western blot analyses. Also, the monosaccharide composition of SGA1 was very different from the other three antigen, suggesting SGA1 was different from LPG, SGA2 and TF1.17. Although LPG reacted with Mabs to native TF1.17 antigen, LPG did not induce an immune response in cattle with the same route and adjuvant used to produce strong antibody responses to the native antigen. The latter response suggests that the tightly bound peptide present in the immunoaffinity-purified antigen is necessary for induction of a response to (an) epitope(s) in TF-LPG and TF1.17. Furthermore, vaginal fluid from T. foetus-infected heifers and serum from a cow with a T. foetus-associated pyometra recognized both TF1.17 and TF-LPG in western blots. These results suggest that T. foetus LPG and SGA2 are related to TF1.17 antigen, which was previously shown to play an important role in the pathogenesis and host response in bovine trichomoniasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11534640     DOI: 10.1645/0022-3395(2001)087[0770:IABAOG]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  6 in total

1.  Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells.

Authors:  Felix D Bastida-Corcuera; Cheryl Y Okumura; Angie Colocoussi; Patricia J Johnson
Journal:  Eukaryot Cell       Date:  2005-11

2.  Murine models of vaginal trichomonad infections.

Authors:  Eduardo R Cobo; Lars Eckmann; Lynette B Corbeil
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

3.  Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function.

Authors:  Bibhuti N Singh; Gary R Hayes; John J Lucas; Ulf Sommer; Nelly Viseux; Ekaterina Mirgorodskaya; Radiana T Trifonova; Rosaria Rita S Sassi; Catherine E Costello; Raina N Fichorova
Journal:  Glycoconj J       Date:  2008-07-06       Impact factor: 2.916

4.  Tritrichomonas foetus induces apoptotic cell death in bovine vaginal epithelial cells.

Authors:  B N Singh; J J Lucas; G R Hayes; Ish Kumar; D H Beach; Marcel Frajblat; R O Gilbert; U Sommer; C E Costello
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

5.  Antibodies to Trichomonas vaginalis surface glycolipid.

Authors:  F D Bastida-Corcuera; B N Singh; G C Gray; P D Stamper; M Davuluri; K Schlangen; R R Corbeil; L B Corbeil
Journal:  Sex Transm Infect       Date:  2013-06-19       Impact factor: 3.519

Review 6.  Vaccines against sexually transmitted diseases.

Authors:  Lynette B Corbeil; Carlos M Campero; Jack C Rhyan; Robert H BonDurant
Journal:  Reprod Biol Endocrinol       Date:  2003-12-02       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.